Our most robust findings based on pleiotropy-robust models and the largest metabolite GWAS data to date suggest that T2D liability increases BCAAs across mid to late adulthood, whilst CAD liability decreases LDL-C and apolipoprotein B in older adults only. This evidence concerns the gene APOB and type 2 diabetes mellitus.